Few studies have investigated whether ethnic groups differ in the prevalence of peripheral arterial disease (PAD). We compared the distribution of the ankle-brachial index (ABI), a measure of PAD, between African Americans and non-Hispanic white individuals. Subjects (nˆ931) belonged to the Genetic Epidemiology Network of Arteriopathy (GENOA) study, a community-based study of hypertensive sibships, and included 453 African Americans from Jackson, Mississipi (mean age 72 6 years, 69% women) and 478 non-Hispanic white individuals from Rochester, Minnesota (mean age 58 7 years, 64% women). ABI was determined at two sites in each lower extremity and the lowest of four indices was used in the analyses. PAD was de ned as an ABI of 0.95. Information about conventional risk factors was derived from interviews and from blood samples drawn at the study visit. The prevalence of diabetes and hypertension was signi cantly higher in African Americans than in non-Hispanic white individuals. After adjusting for age, African American subjects had a lower mean ABI (women 0.97 vs 1.04, p < 0.001; men 0.96 vs 1.12, p < 0.001) and a greater prevalence of PAD (women 34% vs 22% , pˆ0.010; men 33% vs 11% , p < 0.001) than their non-Hispanic white counterparts. In multiple regression analyses, African American ethnicity was a predictor of a lower ABI and the presence of PAD in each sex after adjusting for age and other conventional risk factors. In conclusion, the lower ABI and greater prevalence of PAD in African Americans than in non-Hispanic white individuals is not explained by differences in conventional risk factors. Identifying additional 'novel' risk factors that account for the ethnic differences in PAD is an important next step towards understanding why such differences exist and developing more effective strategies to reduce the burden of PAD.
Introduction
Lower extremity peripheral arterial occlusive disease (PAD ) is a major public health problem in the USA, affecting at least 8-10 million people. 1, 2 The societal impact of PAD is considerable since affected individuals often have widespread atherosclerosis and are at increased risk of stroke, myocardial infarction, and cardiovascular death. [3] [4] [5] The ankle-brachial index (ABI) is an established, non-invasive measure of PAD that correlates with the angiographic extent of the disease. 6 The association of conventional risk factors with the ABI, and with symptoms of intermittent claudication, has been described in several population-based cohorts, including the F ramingham study 3, 7, 8 and the Edinburgh Artery study. 9 Because these epidemiological studies of PAD have focused primarily on white subjects, data regarding nonwhite subjects are sparse. Ethnic differences have been observed in the prevalence of coronary artery calci cation, a measure of coronary atherosclerotic burden. 10 The aim of the present study was to explore ethnic differences in PAD . We hypothesized that signi cant differences may exist in the ABI and prevalence of PAD between African American and non-Hispanic white subjects.
Methods
Subjects included 931 participants in the Genetic Epidemiology Network of Arteriopathy (GENOA) study, a community-based study of hypertensive sibships that aims to identify genes in uencing blood pressure. 11 In the initial phase of the GEN OA study (9=1995 to 6=2001), sibships containing at least two individuals with essential hypertension diagnosed before the age of 60 years were enrolled in Jackson, Mississippi (African American subjects, nˆ1854) and in R ochester, M innesota (non-Hispanic white subjects, nˆ1583). At least 1000 participants at each center are returning in phase II of GEN OA for physical examination, laboratory tests, and measurement of the ABI. Through N ovember 2002, 478 non-Hispanic white individuals from R ochester MN and 453 African American individuals from Jackson MS had completed the phase II study protocol.
H eight was measured by stadiometer, weight by electronic balance, and body mass index (BM I) was calculated as weight in kilograms divided by the square of height in meters. Resting systolic and diastolic blood pressure were measured by random zero sphygmomanometer. The diagnosis of hypertension was established based on blood pressure levels measured at the study visit ( > 140=90 mmHg) or a prior diagnosis of hypertension and current treatment with antihypertensive medications. Diabetes was considered present if the subject was being treated with insulin or oral agents or had a fasting glucose level 126 mg=dl. 'Ever' smoking was de ned as having smoked more than 100 cigarettes. Information about the use of statin medications, estrogen, and aspirin was extracted from a questionnaire completed by the participants.
Blood was drawn by venipuncture after an overnight fast. Serum cholesterol, triglycerides, and high-density lipoprotein (H DL) cholesterol were measured by standard enzymatic methods. At each center, the ABI was measured by examiners who had undergone training in the Mayo Clinic's non-invasive vascular laboratory in R ochester MN . An identical, standardized protocol was used at both centers. F ollowing a 5-min rest, subjects were evaluated in the supine position. Appropriately sized blood pressure cuffs were placed on each arm and ankle, and a Doppler ultrasonic instrument (Medisonics, M inneapolis, M N, USA) was used to detect each pulse. The cuff was in ated to 10 mmHg above systolic pressure and de ated at 2 mmHg=s. The rst reappearance of the pulse was taken as the systolic pressure. To calculate the ABI, the systolic blood pressure at each ankle site was divided by the higher of the two brachial pressures. The lowest of the four ratios was designated as the ABI. The correlation of the lowest ABI with the average of the two ankle-brachial indices from the same leg was 0.98 and inferences were similar using the lowest ABI or the average ABI. Subjects with an ABI greater than 1.30 (nˆ30) were excluded from the analyses as they may have non-compressible arteries due to medial arterial calci cation. 12 Statistical methods LOWESS (locally weighted scatter plot smoothing) regression lines of ABI on age were constructed for women and men in each ethnic group. In the overall sample, a multiple regression model to predict the ABI based on age, sex, ethnicity, and their interactions was constructed. A signi cant interaction was noted between the effects of sex and ethnicity. Hence, subsequent analyses of the effect of ethnicity were strati ed by sex. In each sex, multiple linear regression models were used to investigate the association of ABI with ethnicity after adjusting for categorical risk factors for atherosclerosis (hypertension, type 2 diabetes, and history of smoking) and quantitative risk factors (age, systolic blood pressure, diastolic blood pressure, BMI, total cholesterol, HD L cholesterol, and triglycerides). Likewise, logistic regression was used to test the association of PAD (ABI 0.95) with ethnicity, controlling for age and the other cardiovascular risk factors. P-values of < 0.05 were deemed statistically signi cant. Statistical analyses were performed with SAS v 8.2 (SAS Institute, Cary, N C, U SA).
LOWESS regression lines of ABI on age were constructed using Splus v 6.0 (Insightful Corp., Seattle, WA, USA).
Because of the presence of sibships in the sample, population-averaged generalized estimating equations (GEE) 13 were used to assess the possible impact of familial correlations on the relationships between predictor and outcome variables. Since inferences were the same, only regression results are reported.
Results
The proportion of women in the two ethnic groups did not differ signi cantly (69% vs 64% ; pˆ0.114). Since the African American subjects were signi cantly older than the non-Hispanic white individuals (72 6 vs 58 7 years; p < 0.0001), the sample characteristics in Table 1 are presented with and without adjusting for age. In women, after adjusting for age, the systolic and diastolic blood pressure, BM I, and the percentage of subjects who had hypertension or diabetes were signi cantly greater in African Americans than non-Hispanic white individuals, whereas the mean triglyceride level was signi cantly greater in white individuals than African Americans (Table  1 ). In men, after adjusting for age, the diastolic blood pressure, total cholesterol, and HD L cholesterol levels were signi cantly greater in African Americans than non-Hispanic white individuals (Table 1) . After adjusting for age, the ABI was signi cantly lower and the percent of subjects with an ABI 0.95 was signi cantly greater in African Americans than non-Hispanic white individuals.
Plots of ABI by age using LOWESS regression lines indicated that in each sex the ABI was lower in African Americans than non-Hispanic white individuals at all comparable ages (F igure 1). In a multiple regression model to predict ABI that included age, sex, ethnicity and their interactions, a signi cant interaction was noted between the effects of sex and ethnicity on ABI (pˆ0.012) ( Table 2 ). There was no evidence of interaction of the effects of age with those of either sex or ethnicity. Consequently, subsequent analyses to assess the in uence of ethnicity on ABI and the prevalence of PAD were strati ed by sex. In multiple regression models, African American ethnicity was an independent predictor of a lower ABI in each sex (Table 3 ). In women, additional signi cant predictors of a lower ABI included older age, age 2 , higher systolic blood pressure, diabetes, and history of smoking. In men, additional predictors of a lower ABI included higher systolic blood pressure and history of smoking. In both sexes, lower BMI was also an additional predictor of a lower ABI.
In logistic regression models, African American ethnicity was associated with signi cantly increased odds of having an ABI 0.95 (Table 4 ). After adjusting for age and the other risk factors, the odds of PAD associated with African American versus non-Hispanic white ethnicity was 4.75 (95% CI: 1.4-16.0) in men and 2.23 (95% CI: 1.2-4.2) in women.
Discussion
The main nding of this study is that African American ethnicity is associated with a lower ABI and higher prevalence of PAD in a cohort of predominantly hypertensive subjects. The lower ABI and greater prevalence of PAD in African Americans is not explained by their greater burden of conventional risk factors. Atherosclerosis affects the arterial bed in a diffuse but non-uniform manner. The biological basis of the regionality of atherosclerosis is not fully understood. Likewise, it is not known whether this regionality differs among ethnic groups. African Americans have less coronary artery calcication (CAC) than non-H ispanic white individuals with a similar burden of conventional risk factors. 10 In contrast, our ndings suggest that African Americans have a higher prevalence of PAD than non-Hispanic white individuals after adjusting for differences in conventional risk factors. Similar ndings were reported by the Cardiovascular Health Study, which assessed the relation of ABI to cardiovascular risk factors and subclinical cardiovascular disease in subjects older than 65 years. 14, 15 Non-white ethnicity (predominantly African American) was associated with a lower ABI independent of risk factors including diabetes, BM I, and smoking. In the ARIC study, the prevalence of PAD was higher in black than white people, and higher in women than men. 16 The adjusted odds ratio of PAD associated with African American ethnicity in women in our study was similar to those in the above two studies. F or men, the adjusted odds ratio was higher in our study, albeit with large con dence intervals. This could be due to the low prevalence of PAD in non-Hispanic white individuals. Alternatively, in this predominantly hypertensive cohort, African American ethnicity may truly have a stronger effect on the causation of PAD in men. Moreover, in non-white subjects (predominantly African Americans), symptomatic PAD was associated with worse clinical outcomes than in non-Hispanic white subjects. 17 The association of ethnicity with a lower ABI may be due to both genetic and environmental factors. D ata from the Bogalusa H eart Study 18 is suggestive of a genetic contribution to ethnic differences in PAD . In that study, during adolescence and early adulthood, African Americans had approximately 1.5 times as much aortic surface involvement of fatty streaks as did non-Hispanic white individuals. This additional aortic surface involvement of fatty streaks in African Americans was not due to differences in antemortem levels of serum lipids and lipoproteins, blood pressure, or obesity. An excess of fatty streaks in the coronary arteries of African Americans was not observed. Ethnic differences in PAD later in life may also be due to differential exposure to environmental factors, both known and unknown. Ethnicity may index socioeconomic differences and differences in access to care, duration of exposure to risk factors, and in the prevalence of novel risk factors.
In non-Hispanic white, but not in African American individuals, the ABI was signi cantly lower in women than men. The difference between men and women among non-Hispanic white individuals was no longer statistically signi cant after adjusting for height (analysis not shown). These ndings are similar to those of H iatt and colleagues 1 who studied 403 subjects from a bi-ethnic population of Hispanics and non-Hispanic white individuals. ABIs were signi cantly lower in women than in men (on average by 0.07). Height had a signi cant but modest effect on ankle pressure and after adjusting for height, the difference in ABI values between men and women was reduced but remained statistically signi cant. Prior ethnic and gender comparison of ABIs have been published but only in an abstract form. 19 In this report, ABIs were lower in African American than in white individuals, and lower in women than in men. 19 However, the prevalence of claudication or severe PAD does not appear to be higher in women. 20 The in uence of gender on PAD needs further study. 20, 21 The relation of several risk factors to the ABI was similar in both ethnic groups. As expected, systolic blood pressure was inversely related to ABI. Although hypertension was not related to ABI, this may have been because the majority of subjects were hypertensive. Although the association of a higher BM I with a higher ABI was unexpected, a similar association was noted in the Cardiovascular Health Study. 14 We noted that the association between BMI and ABI was not strictly linear and in subjects with a BMI > 35, BM I was inversely related to ABI (analysis not shown). Plasma lipid levels were not associated with ABI in either cohort, perhaps because the in uence of lipids on PAD may diminish with increasing age and in the presence of hypertension.
Several limitations of our study need to be considered. There was considerable age difference in the two cohorts. However, even after adding a non-linear age term (age age) into the regression model, as well as reestimating the model limiting the age range to the interval from the youngest African American to the oldest non-Hispanic white subjects, the effect of ethnicity remained signi cant in both men and women (analysis not shown). The African American cohort was selected from a region with some of the highest rates of cardiovascular events in the USA, 22 and may not be representative of African Americans from other regions. We studied cohorts of predominantly hypertensive subjects and therefore our ndings may not be generalizable to the general population. Data regarding the presence of claudication were not available. H owever, the Rose questionnaire for claudication is not a sensitive measure for the presence of PAD. 15 M oreover, symptoms of claudication are poorly correlated with the angiographic extent of lower extremity PAD. 6
Conclusion
The lower ABI and greater prevalence of PAD among African Americans than non-Hispanic white individuals are not explained by differences in conventional risk factors and may be due to unmeasured environmental as well as genetic factors. Identifying additional biochemical and genetic risk factors that account for these unexplained ethnic differences in PAD is an important next step towards understanding why such differences exist and developing more effective strategies to reduce the burden of this disease. Ethnic differences in peripheral arterial disease 241
